These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38413593)

  • 41. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
    Pollard AJ; Launay O; Lelievre JD; Lacabaratz C; Grande S; Goldstein N; Robinson C; Gaddah A; Bockstal V; Wiedemann A; Leyssen M; Luhn K; Richert L; Bétard C; Gibani MM; Clutterbuck EA; Snape MD; Levy Y; Douoguih M; Thiebaut R;
    Lancet Infect Dis; 2021 Apr; 21(4):493-506. PubMed ID: 33217361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques.
    Chen L; Ewing D; Subramanian H; Block K; Rayner J; Alterson KD; Sedegah M; Hayes C; Porter K; Raviprakash K
    J Virol; 2007 Nov; 81(21):11634-9. PubMed ID: 17715224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis.
    Gardner CL; Burke CW; Tesfay MZ; Glass PJ; Klimstra WB; Ryman KD
    J Virol; 2008 Nov; 82(21):10634-46. PubMed ID: 18768986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus.
    Atasheva S; Wang E; Adams AP; Plante KS; Ni S; Taylor K; Miller ME; Frolov I; Weaver SC
    Vaccine; 2009 Jul; 27(32):4309-19. PubMed ID: 19446595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eastern Equine Encephalitis Virus in the United States, 2003-2016.
    Lindsey NP; Staples JE; Fischer M
    Am J Trop Med Hyg; 2018 May; 98(5):1472-1477. PubMed ID: 29557336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice.
    Gardner CL; Yin J; Burke CW; Klimstra WB; Ryman KD
    Virology; 2009 Aug; 390(2):338-47. PubMed ID: 19539968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of murine B-cell epitopes on Eastern equine encephalitis virus glycoprotein E2.
    EnCheng S; Jing Z; Tao Y; QingYuan X; Yongli Q; WenShi W; Peng W; Liang S; Jing S; DongLai W
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6359-72. PubMed ID: 23512478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aerosol infection of cynomolgus macaques with enzootic strains of venezuelan equine encephalitis viruses.
    Reed DS; Lind CM; Sullivan LJ; Pratt WD; Parker MD
    J Infect Dis; 2004 Mar; 189(6):1013-7. PubMed ID: 14999604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypervariable Domain of Eastern Equine Encephalitis Virus nsP3 Redundantly Utilizes Multiple Cellular Proteins for Replication Complex Assembly.
    Frolov I; Kim DY; Akhrymuk M; Mobley JA; Frolova EI
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains.
    Adams AP; Aronson JF; Tardif SD; Patterson JL; Brasky KM; Geiger R; de la Garza M; Carrion R; Weaver SC
    J Virol; 2008 Sep; 82(18):9035-42. PubMed ID: 18614636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response to and efficacy of vaccination against eastern equine encephalomyelitis virus in emus.
    Tengelsen LA; Bowen RA; Royals MA; Campbell GL; Komar N; Craven RB
    J Am Vet Med Assoc; 2001 May; 218(9):1469-73. PubMed ID: 11345313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice.
    Ma J; Wang H; Zheng X; Xue X; Wang B; Wu H; Zhang K; Fan S; Wang T; Li N; Zhao Y; Gao Y; Yang S; Xia X
    Int Immunopharmacol; 2014 Mar; 19(1):74-80. PubMed ID: 24440303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs.
    Roy CJ; Reed DS; Wilhelmsen CL; Hartings J; Norris S; Steele KE
    Virol J; 2009 Oct; 6():170. PubMed ID: 19852817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).
    Dye JM; Warfield KL; Wells JB; Unfer RC; Shulenin S; Vu H; Nichols DK; Aman MJ; Bavari S
    Viruses; 2016 Apr; 8(4):94. PubMed ID: 27070636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein.
    Kim AS; Austin SK; Gardner CL; Zuiani A; Reed DS; Trobaugh DW; Sun C; Basore K; Williamson LE; Crowe JE; Slifka MK; Fremont DH; Klimstra WB; Diamond MS
    Nat Microbiol; 2019 Jan; 4(1):187-197. PubMed ID: 30455470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
    Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
    Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.